ORIC Pharmaceuticals logo
ORIC Pharmaceuticals ORIC
$ 9.01 3.09%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

ORIC Pharmaceuticals Income Statement 2011-2024 | ORIC

Annual Income Statement ORIC Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

771 M 201 M 558 M 889 M - - - - - - - - -

Shares

51.5 M 39.7 M 38 M 30.3 M - - - - - - - - -

Historical Prices

15 5.07 14.7 33.9 - - - - - - - - -

Net Income

-101 M -89.1 M -78.7 M -73.7 M -26.9 M -21.4 M - - - - - - -

Revenue

- - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-111 M -91.8 M -78.9 M -74.2 M -28.6 M -22.4 M - - - - - - -

Interest Expense

- - - - - - - - - - - - -

EBITDA

-110 M -90.8 M -78 M -73.2 M -27.5 M -21.5 M - - - - - - -

Operating Expenses

111 M 91.8 M 78.9 M 74.2 M - - - - - - - - -

General and Administrative Expenses

25.6 M 25.1 M 22 M 13.4 M 5.72 M 3.34 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement ORIC Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

70.5 M 70.3 M 67.3 M 54.9 M 57.4 M 45.7 M 45.1 M 45.1 M 39.6 M 39.5 M 39.4 M 39.4 M 39 M 36.7 M 36.7 M 36.7 M 30.3 M 21.6 M 1.99 M 1.98 M 1.95 M 1.87 M 1.81 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-34.6 M -32 M -25 M - -25.5 M -22.9 M -23.9 M - -24.8 M -20.3 M -23.2 M - -18.4 M -21 M -16.5 M - -25.5 M -11 M -8.87 M - -6.55 M -5.96 M -6.02 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-38.3 M -36 M -29 M - -28.7 M -25 M -25.7 M - -25.7 M -20.7 M -23.3 M - -18.5 M -21.1 M -16.6 M - -25.6 M -11.1 M -9.18 M - -7.1 M -6.36 M -6.35 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -28.7 M - - - -25.4 M - -25 M -20.2 M -23 M - -17.8 M -20.6 M -16.3 M - -24.9 M -10.6 M -8.93 M - -6.34 M -5.87 M -6.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

38.3 M 36 M 29 M - 28.7 M 25 M 25.7 M - 25.7 M 20.7 M 23.3 M - 18.5 M 21.1 M 16.6 M - 25.6 M 11.1 M 9.18 M - 7.1 M 6.36 M 6.35 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

7.12 M 7.08 M 7.03 M - 6.29 M 6.2 M 6.16 M - 5.97 M 6.86 M 6.43 M - 5.56 M 5.54 M 4.86 M - 3.8 M 3.4 M 1.92 M - 1.46 M 1.32 M 1.13 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency